Population
Patients with symptomatic severe aortic stenosis deemed too high risk for surgical aortic valve replacement
Design
Review
Authors
Loading...
Affirms TAVR as standard for high-risk severe aortic stenosis; leaves open questions on complications and lower-risk expansion.
TAVR has become an established therapy for high-risk patients with symptomatic severe aortic stenosis, though complications and its role in lower-risk patients remain areas of ongoing evaluation.
Tang et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: